CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis

Targeting CD47 efficiently enhances macrophage phagocytosis in both physiological and pathological conditions. Anti-CD47 antibodies have been shown to inhibit the progression of several types of cancer. However, the mechanism of anti-CD47 monoclonal antibody (mAb) treatment remains controversial. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ran, Wei, Huiting, Gao, Peng, Yu, Hu, Wang, Ke, Fu, Zheng, Ju, Baohui, Zhao, Meng, Dong, Shangwen, Li, Zhijun, He, Yifeng, Huang, Yuting, Yao, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503592/
https://www.ncbi.nlm.nih.gov/pubmed/28380460
http://dx.doi.org/10.18632/oncotarget.16547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503592/
https://www.ncbi.nlm.nih.gov/pubmed/28380460
http://dx.doi.org/10.18632/oncotarget.16547

Ejemplares similares